• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Stock Trend Alerts

Essential Market Ideas and Investing Strategies

  • Newsletter Reviews
  • Hot Stocks
  • Technology
  • Financial News
  • Secrets of the Pros
  • Analysis
Home » Biotech Sector Poised for Major Upswing?

Biotech Sector Poised for Major Upswing?

My career has been what you might call “nontraditional.”

Very few Wall Street analysts spent their early 20s doing theater in Greenwich Village.

When I started teaching myself about investing – just because I was a struggling actor didn’t mean I had to be a starving actor – I learned how to read financial statements and analyze companies (fundamental analysis). Then, when I started trading, I studied price action (technical analysis).

After a few months at my job as a fundamental analyst with the most contrarian research firm on Wall Street, I was approached by my boss, who’d heard I knew about technical analysis. Imagine my surprise when he asked me to start writing a technical analysis note for clients every morning.

Since then, I’ve always used technical analysis as a timing tool when looking at a stock or sector.

Today, I’m shining my technical analysis light on the biotech sector.

The biotech sector can be volatile. Biotech stocks can have big swings depending on earnings, clinical trial data or regulatory approvals.

Over the past 10 years, the sector has outperformed the overall market. The sector, as represented by the iShares Biotechnology ETF (Nasdaq: IBB), is up 407% while the S&P 500 has gained 352%.

[Hot New Tech: This odd-looking machine could be the most transformative innovation in history]

Recently, however, the sector hasn’t been great. Since hitting a high of $177.37 in August, the biotech exchange-traded fund (ETF) is down 11%. Meanwhile, the S&P 500 is up 2.5% over the same period.

Despite the recent drop in the biotech sector, I like its technical setup.

Shown below is a weekly chart going back three years. It shows the performance of the ETF up close.

You can see that the iShares Biotechnology ETF has made higher highs and higher lows, an important feature of an uptrend.

Furthermore, the reading on the bottom of the chart is a technical indicator called a stochastic oscillator. It is a measure of momentum. Whenever stochastics hit 20 (like the instances circled in blue on the chart), the stock is considered oversold. You can see that over the past three years, practically every time stochastics neared 20, the ETF rallied.

[Discover: The off the radar Small-Cap Stock at the center of an Era-Defining Technology]

Today, stochastics are very oversold and starting to turn higher, which suggests a move higher is imminent.

Lastly, the 50-week moving average is at $158.58. The moving average has acted as support and resistance in the past.

As a refresher…

Support: An area where a stock stops moving lower.

Resistance: An area where a stock stops moving higher.

When a security crosses its moving average to the upside, that is a very bullish sign.

If we drill down to the one-year daily chart, shown below, you can see stochastics have already turned higher and the ETF is up against a 200-day moving average. Similar to the 50-week moving average, it acts as support and resistance.

[Breakthrough: Scientists Predict this Industry Could Grow Nearly 200,000% in Just Four Years]

Seeing as the two moving averages are close to the same price, if the iShares Biotechnology ETF trades at around $165, that is a break of two important areas of resistance (its two moving averages). That indicates the price will continue higher from there.

The top three holdings in the iShares Biotechnology ETF are Amgen (Nasdaq: AMGN), Moderna (Nasdaq: MRNA) and Gilead Sciences (Nasdaq: GILD). But once the ETF crosses over those two moving averages, it’s game on for the entire sector, not just the top stocks in the ETF.

Use your research skills to find great companies and stocks you want to invest in, and then use technical analysis to better time your buys and sells.

It’s not a traditional way of investing, as most investors use only one of those two methods. But when it comes to investing, I’ve never been very traditional.

[“Imperium” – The Next Intel: The Microchip Company Powering the 199,000% DNA Mega Trend]

Read more from Marc Lichtenfeld at WealthyRetirement.com

You Might Also Like...

  • Semiconductor Stock Headed for Major Milestone as Global Demand Intensifies...
  • The Next Great Opportunity for Energy Investors?
  • Latest Offshore Wind Farms Present a Big Opportunity for Energy Investors
  • Tesla Reveals Plans for Humanoid Robot and Supercomputer Chip at AI Day

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Subscribe to Stock Trend Alerts

By submitting your email address, you give Stock Trend Alerts permission to deliver investment research to your email inbox. Privacy Policy | How It Works

Popular Posts

  • Martin Weiss Docket No. OP–1670: 12 Inflation-Beating Stocks
  • Jim Rickards – The Return of American Energy: Profit from the Green Lie
  • Andrew Zatlin: Biden’s Puppet Master Exposed and How to Opt Out of the Digital Dollar
  • Why 2023 Could Kick Off a “Cash Frenzy” in Stocks
  • Dylan Jovine 21st Century Battlefield: 4 Companies Changing Warfare
  • Infinite Energy Stock: The Tiny Company Dominating Tesla in the Trillion-Dollar Green Energy Race
  • Dylan Jovine Search & Destroy: 3 AI Software Stocks Revolutionizing Warfare
  • BREAKING: Military to spend billions on “Living Missile”

Recent Posts

  • 25 Super-Woke Companies You Do Not Want in Your Portfolio with Alexander Green
  • Jeff Clark Trader: The Currency Trading Retirement Blueprint
  • Jason Williams Blue Gas: The Tesla Killer Fuel Cell Revolution
  • Andrew Zatlin: Biden’s Puppet Master Exposed and How to Opt Out of the Digital Dollar
  • The AI Takeover: Jason Bodner’s Quantum Edge Trader Smart Tech

Topics

AAPL Advertorial Amazon AMZN Artificial Intelligence Battery Bear Market Biotech Bitcoin Blockchain Clean Energy Cloud Computing Coronavirus COVID Creative Cryptocurrency Dividends E-Commerce Electric Vehicles Elon Musk Energy Ethereum Gold Growth Stocks Inflation Interest Rates International Jeff Brown Louis Navellier Market Crash MSFT Oil and Gas Options Prediction President Biden Recession Retirement Russia Semiconductor Supply Chain Tesla The Fed TSLA Volatility Warren Buffett

Copyright © 2023 · Stock Trend Alerts - Essential Market Moves and Investing Ideas

Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.

Stock Trend Alerts, its managers, its employees, affiliates and assigns (collectively "The Company") do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.

The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. The Company is not affiliated with, nor does it receive compensation from, any specific security.

To the maximum extent permitted by law, the Company disclaims any and all liability in the event any information, commentary, analysis, opinions, advice and/or recommendations provided herein prove to be inaccurate, incomplete or unreliable, or result in any investment or other losses.

About Us | How it Works | Privacy Policy | Terms and Conditions | Contact Us